Paolo G. Casali Annalisa Trama
|
|
|
- Dustin Terry
- 6 years ago
- Views:
Transcription
1 Paolo G. Casali Annalisa Trama
2
3 Objectives With regard to RCs in the EU, to improve: 1. Epidemiological surveillance 2. Quality of care through ERNs 3. Clinical practice guidelines 4. Innovation 5. Medical and Patient education 6. Health policy measures 7. Patient empowerement
4 Work packages WP 1 Coordination INT, IT 2 Dissemination NKUA, GR 3 Evaluation CSF, FI 4 Epidemiology INT, IT 5 Assuring Quality of Care OECI 6 Clinical practice guidelines DKG, DE 7 Innovation and access to innovation WIV-ISP, BE 8 Medical education UP, HU 9 Childhood Cancers SIOPE 10 Rare Cancer Policy ICO, ES
5 18 MSs 34 ass. partners
6 Collaborating partners European Cancer Patients Coalition (ECPC) University College of London-Institute of Child Health (UCL-ICH) European School of Oncology (ESO) European Medicine Agency (EMA) European Network of Cancer Registry (ENCR) Joint Research Centre (JRC) Belgian Cancer Registry (BCR) Italian National Institute of Health (Istituto Superiore di Sanità) European Society for Medical Oncology (ESMO) Istituto Superiore di Sanità (ISS - Rare Best Practice) European Organisation for Research and Treatment of Cancer (EORTC) Anticancerfund Association of European Cancer Leagues (ECL) European Society of Surgical Oncology (ESSO) Childhood Cancer International (CCI-Europe) St. Anna Children's Cancer Research Institute (CCRI) Rare Cancer Europe (RCE) EFPIA-EuropaBio University of Milan Hospital Universitario y Politécnico La Fe. GICT-Cáncer IIS La Fe, (CICT)
7 .
8 Deliverables
9
10 1. Pediatric cancers 2. Haematologic rare neoplasms Eur J Cancer 2011;47: Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head & neck cancers 7. Central nervous system tumours 8. Rare female genital cancers 9. Rare urological and male genital tumours 10. Endocrine gland tumours 11. Digestive rare cancers 12. Rare skin cancers & non-cutaneous melanoma
11
12 promote good quality and safe care to patients by fostering proper diagnosis, treatment, follow-up and management of patients across the Network empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient pathways exchange, gather and disseminate knowledge, evidence and expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through setting up of shared registries exchange and disseminate knowledge and best practices, in particular by supporting national centres and networks
13 promote good quality and safe care to patients by fostering proper diagnosis, treatment, follow-up and management of patients across the Network empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient pathways exchange, gather and disseminate knowledge, evidence and expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through setting up of shared registries exchange and disseminate knowledge and best practices, in particular by supporting national centres and networks
14 promote good quality and safe care to patients by fostering proper diagnosis, treatment, follow-up and management of patients across the Network empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient pathways exchange, gather and disseminate knowledge, evidence and expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through setting up of shared registries exchange and disseminate knowledge and best practices, in particular by supporting national centres and networks
15 SARCOMAS Frankfurt, 18 April 2017
16 Consensus development
17 Multidisciplinary cancer teams
18 Evidence basis
19 Care pathways evidence-based consensus willingness to pay
20 «Big data» BIG CLINICAL DATA & RCs Milan, Q Methodological implications (vs clinical trials!) Technological windows of opportunity Added values for rare cancers
21 promote good quality and safe care to patients by fostering proper diagnosis, treatment, follow-up and management of patients across the Network empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient pathways exchange, gather and disseminate knowledge, evidence and expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through setting up of shared registries exchange and disseminate knowledge and best practices, in particular by supporting national centres and networks
22 .
23
24
25 Fellowships Distance tutoring European Joint Doctorates Research and Innovation Staff Exchanges (RISE)..
26 1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head & neck cancers 7. Central nervous system tumours 8. Rare female genital cancers 9. Rare urological and male genital tumours 10. Endocrine gland tumours 11. Digestive rare cancers 12. Rare skin cancers & non-cutaneous melanoma
27 promote good quality and safe care to patients by fostering proper diagnosis, treatment, follow-up and management of patients across the Network empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient pathways exchange, gather and disseminate knowledge, evidence and expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through setting up of shared registries exchange and disseminate knowledge and best practices, in particular by supporting national centres and networks
28
29 Networking
30
31
32
Introduction. Paolo G. Casali
Introduction Paolo G. Casali paolo.casali@istitutotumori.mi.it rare diseases rare diseases rare cancers cancer rare cancers Rare cancers childhood Rare cancers childhood haematological Rare cancers childhood
FACTS FOCUS ON. The JARC will focus on the 12 families of rare cancers
FACTS 198 different types of cancer, including all childhood cancers, affect only a small number of patients each. 24% of new diagnosis of cancers are of rare cancers Patients struggle with: late or incorrect
Putting Patient Care First
Putting Patient Care First EU Joint Action on Rare Cancers (JARC) The final goal of the Action will be to contribute to improve health outcomes for patients with rare cancers and to decrease health inequalities
Partnerships. 18 MSs 34 ass. partners 24 coll. partners
Partnerships 18 MSs 34 ass. partners 24 coll. partners LIST OF BENEFICIARIES Number Short Name Legal Name Country 1 INT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI IT 2 UoA ETHNIKO KAI KAPODISTRIAKO
LIST OF RARE CANCERS AND ITS RATIONALE
Forth Eastern European Conference for Rare Diseases and Orphan Drugs Together for Integrative approach to Rare Diseases 13-14 June 2009 Plovdid, Bulgaria LIST OF RARE CANCERS AND ITS RATIONALE Annalisa
The EU rare diseases policy framework: the context for ERNs
The EU rare diseases policy framework: the context for ERNs Jaroslaw Waligora DG Health and Food Safety, European Commission Unit C.1, Programme Management and Diseases Report from an expert group of the
Table Of Content. Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners... 5 National University Specialised Hospital for Active Treatment in Oncology - NOH... 5
EUROCARE STEERING COMMITTEE DRAFT MINUTES
Steering Committee (SC) Participants EUROCARE STEERING COMMITTEE 18.09.2013 DRAFT MINUTES Magdalena Bielska Lasota, Maja Zakelj, Renèe Otter, Marc Colonna,, Rafael Marcos Gragera, Michel Coleman, Mats
rare diseases research through National Plans and Strategies
Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute
ESMO 2020 VISION. esmo.org
ESMO 2020 VISION esmo.org CARING FOR PEOPLE WITH CANCER Cancer patients and their needs are at the centre of all that we do: our profession is driven by our determination, individually and collectively,
EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
Josep M Borras WP7 Health Care University of Barcelona and Spanish Cancer Strategy Brussels, June 23, 2014
THE IMPORTANCE OF SHARING EXPERTISE AND THE CHALLENGE TO MANAGE THE EXCHANGE OF KNOWLEDGE IN HIGHLY SPECIALISED HEALTH CARE: a perspec(ve from the European Partnership Ac(on Against Cancer (EPAAC) Josep
A multi-stakeholder partnership initiative. 10 February 2012
A multi-stakeholder partnership initiative 10 February 2012 1 History 39 recommendations on stakeholder actions and public policies:» 8 addressing regulatory barriers in rare cancer care» 11 addressing
Table Of Content. Outputs... 9
Table Of Content European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Klinikum Dortmund ggmbh... 5 Uniwersytet
European Partnership for Action Against Cancer
ESPEN Congress Barcelona 2012 Achieving goals by guidelines: myth or reality? European Partnership for Action Against Cancer J.M. Borras European Partnership for Action Against Cancer Josep M Borras WP7
European Guide on Quality Improvement in Comprehensive Cancer Control
European Guide on Quality Improvement in Comprehensive Cancer Control 13 March 2013, JRC, Ispra Presentation prepared by the National Institute of Public Health of Slovenia OBJECTIVES 1) To identify key
INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation
INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) GENERAL INFORMATION The Innovative Partnership for Action Against Cancer (ipaac) Joint Action, which has been selected for funding under the Third
Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission
Meeting with EMA: cooperation in the field of ERNs Enrique Terol DG SANTE European Commission London 16 May 2017 The road to European Reference Networks (ERNs) Imagine if the best specialists from across
RARECARENet country report Belgium
RARECARENet country report Belgium Draft for review 4 th July 2016 Table of Contents 1. Introduction... 3 2. The epidemiology of rare cancers in Belgium... 4 3. Quality indicators for centres of expertise
Presentation of Istituto Superiore di Sanità, Rome, Italy
Presentation of Istituto Superiore di Sanità, Rome, Italy Health Literacy and Health Education Graz, November 24, 2011 Maurella Della Seta, Documentation Service, ISS maurella.dellaseta@iss.it Istituto
NORDIC CONFERENCE ON RARE DISEASES
www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases
RARE-Bestpractices Project. Final Conference
RARE-Bestpractices Project Final Conference Domenica Taruscio RARE-Bestpractices Leader Director National Centre for Rrae Diseases Istituto Superiore di Sanità Roma RARE-Bestpractices Platform for sharing
Discovery and validation of novel. Webinar IMI2 - Call 9 Joint influenza vaccine effectiveness studies
Discovery and validation of novel Webinar IMI2 - Call 9 Joint influenza vaccine effectiveness studies Dr. Angela Wittelsberger, IMI IMI webinar 29.04.2016 Today s webinar Will cover all aspects of the
Rare Cancer Perspective in the EUCERD
EURORDIS' activities on EU and National Policies Rare Cancer Perspective in the EUCERD Jan Geissler Alternate Member, EU Committee of Experts for Rare Diseases (EUCERD) Director, European Patients Academy
Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter (EN)... 7 D01 - Activity Report EURORDIS
ECPC ANNUAL CONGRESS ECPC GENERAL ASSEMBLY
ECPC ANNUAL CONGRESS FRIDAY 8 SATURDAY 9 JUNE 2018 & ECPC GENERAL ASSEMBLY SUNDAY 10 JUNE 2018 VENUE: RENAISSANCE BRUSSELS HOTEL, RUE DU PARNASSE 19, 1050 BRUXELLES EVENT ORGANISED UNDER THE HIGH PATRONAGE
Soft Tissue Sarcoma: What is best practice?
Soft Tissue Sarcoma: What is best practice? 18:30-19:45, Thursday 10th November 2016 Opala Rooms I, II and III, 1st Floor, Corinthia Hotel Lisbon Chaired by Alessandro Gronchi With Angelo Paolo Dei Tos,
National Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th,
National Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th, 2017 1 European Reference Networks http://ec.europa.eu/health/ern/toolkit_en A European Framework for Rare Disease Services:
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare
Enerca: The European Network for Patients with Rare Anaemias
Mini Review imedpub Journals http://wwwimedpub.com Journal of Rare Disorders: Diagnosis & Therapy DOI: 10.21767/2380-7245.100009 Enerca: The European Network for Patients with Rare Anaemias Joan-Lluis
2017 Products and Services Catalogue esmo.org
2017 Products and Services Catalogue esmo.org This brochure provides you with some information about the valuable products and services offered by ESMO. Being an ESMO member makes you a part of an international
E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY
E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY E-RARE THE ERA-NET FOR RESEARCH PROGRAMMES ON RARE DISEASES MAJOR FACTS ABOUT E-RARE ERA-NET
Fit4RareFit4All Conference Cluj - Napoca 3-4 September 2017
Fit4RareFit4All Conference Cluj - Napoca 3-4 September 2017 Rare diseases registries as key tools in research and public health Domenica Taruscio Director, National Centre for Rare Diseases Istituto Superiore
OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE
OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE Thierry PHILIP President OECI October 3rd 2018, afternoon 1 OECI POSSIBLE EVOLUTION WITHIN THE MISSION EUROPE OECI EUROPEAN CANCER CENTRES France Belgium
Introduction. Legislation & Policy Context
Consumer Participation Plan 2017-2018 1 Introduction Barwon South Western Regional Integrated Cancer Service (BSWRICS) is committed to improving the experiences and outcomes of those affected by cancer
ESMO Clinical Practice Guidelines. ECCO GUIDELINES FORUM Brussels, November 27
ESMO Clinical Practice Guidelines ECCO GUIDELINES FORUM Brussels, November 27 ESMO Clinical Practice Guidelines ESMO Consensus Conferences ESMO Pocket & Mobile Guidelines ESMO Guides for Patients History
SNOMED CT EXPO 2017 Bratislava, 19 October 2017
European Reference Networks SNOMED CT EXPO 2017 Bratislava, 19 October 2017 #ERNEU @EU_Health Tapani PIHA Head of Unit Cross-border healthcare and ehealth Directorate-General Health and Food Safety (DG
European Paediatric Network Legal Basis
Enpr-EMA Joint DIA/EFGCP/EMA Paediatric Forum 26 September 2011 Paolo Rossi Chairman Dept. of Pediatrics Tor Vergata University-Children s Hospital Bambino Gesù, Rome EnprEMA-PDCO Representative An agency
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 23.9.2014 COM(2014) 584 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
Table Of Content. EUROCHIP-III "Common Actions"... 2 Summary... 3 Coordinator, Leader contact and partners Outputs... 7
Table Of Content EUROCHIP-III "Common Actions"... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Integraal Kankercentrum Noord-Nederland - IKN... 5 Suomen Syöpäyhdistys R.Y. (Cancer Society
Organisation of European Cancer Institutes European Economic Interest Grouping. Magazine. Number 1 - Year 2 May 2018
Organisation of European Cancer Institutes European Economic Interest Grouping Magazine Number 1 - Year 2 May 2018 In memory of our dear Thomas On behalf of the OECI Mahasti Saghatchian Gustave Roussy
SUBSPECIALIST TRAINING PROGRAMME
EUROPEAN BOARD AND COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS (EBCOG) AND EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY (ESGO) SUBSPECIALIST TRAINING PROGRAMME IN GYNAECOLOGICAL ONCOLOGY This Programme
ESMO Study of formulary listing, out of pocket cost and actual availability of anti neoplastic agents in Europe Preliminary Findings
ESMO Study of formulary listing, out of pocket cost and actual availability of anti neoplastic agents in Europe Preliminary Findings Nathan I Cherny Norman Levan Chair in Humanistic Medicine Dept Oncology
Table Of Content. SSI_FY Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8
Table Of Content SSI_FY2014... 2 Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8 D01 - EuroMOMO system (EN)... 8 D02 - EuroMOMO website (EN)... 8 D03 - End of influenza season mortality
Access to Clinical Trials International Initiatives
Access to Clinical Trials International Initiatives Stefan Bielack Cooperative Osteosarcoma Study Group COSS Stuttgart Cancer Center Klinikum Stuttgart Olgahospital Zentrum für Kinder-, Jugend- und Frauenmedizin
Table Of Content. European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9
Table Of Content European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9 Network Management... 9 Promote cross-border expert healthcare... 9 Harmonize specialized care... 9
Health care guidelines, recommendations, care pathways
II European Reference Network Conference From planning to implementation Lisbon, 8-9 October 2015 Health care guidelines, recommendations, care pathways Paola Laricchiuta National Centre for Rare Diseases
Rare cancers Medical oncologist Point of View
Rare cancers Medical oncologist Point of View Isabelle Ray-Coquard, MD PhD Centre Léon Bérard GINECO & Université Claude Bernard Lyon I Identified factors to explain medical practices Initial Medical school
Annals of Oncology Advance Access published July 10, 2014
Annals of Oncology Advance Access published July 10, 2014 1 Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1):
3 RD ESO-ESMO-RCE PRECEPTORSHIPS & ClINICAl UPDATE ON RARE ADUlT SOlID CANCERS. 1-3 December 2018 Milan, Italy COURSES AND SEMINARS
3 RD ESO-ESMO-RCE PRECEPTORSHIPS & ClINICAl UPDATE ON RARE ADUlT SOlID CANCERS 1-3 December 2018 Milan, Italy Chairs: J.Y. Blay, FR P.G. Casali, IT R. Stahel, CH Held in collaboration with In the framework
The basics a. Mission Statement (unchanged) eurordi s.org
The basics a. Mission Statement (unchanged) To build a strong pan-european community of patient organisations and people living with rare diseases, To be their voice at the European level And directly
A Summary of Childhood Cancer Statistics in Australia,
What is the Australian Paediatric Cancer Registry (APCR)? The APCR is one of only a few national registries of childhood cancer in the world. It covers all Australian children aged 0-14 years old at diagnosis.
COOPERATION FOR INCREASED SCIENTIFIC CAPACITY
COOPERATION FOR INCREASED SCIENTIFIC CAPACITY Guilhem de Seze Head of Scientific Evaluation of Regulated Products Department, European Food Safety Authority (EFSA) Japan International Conference, 25-26
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit Contract number: 2010 21 02 Acronym: QUANDHIP INTERIM REPORT 02_2013 Proposal title: Quality
Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO
Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'
Deliverable 10: Standard of care guidelines for VRT and very rare STS. ExPO-r-Net Chafea Project Grant Nr
Deliverable 10: Standard of care guidelines for VRT and very rare STS This publication arises from the project ExPO-r-Net which has received funding from the European Union in the framework of the Health
ASCONA 07/11/08 PAEDIATRIC ONCOLOGY. 2 nd ESO-SIOPE MASTERCLASS IN November 2008 Ascona, Switzerland
MASTERCLASS ASCONA 07/11/08 2 nd ESO-SIOPE MASTERCLASS IN PAEDIATRIC ONCOLOGY 7-13 November 2008 Ascona, Switzerland Chair: R. Riccardi, IT - M.C.G. Stevens, UK - A. Eggert, DE Educational Advisor: W.
NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.
D. Taruscio and L. Vittozzi National Centre for Rare Diseases National Institute of Health Rome, Italy NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT. ICORD 2014, Ede
Cancer Control Joint Action Policy Conference Cancer Survivorship: a policy dialogue. Survivorship and the French example
Cancer Control Joint Action Policy Conference Cancer Survivorship: a policy dialogue Survivorship and the French example Committee of the Regions - Brussels - 13/05/2015 STRUCTURE OF THE PRESENTATION I.
WORK PACKAGE 4: LIFETIME COST OF CHILDHOOD OBESITY
JOINT ACTION ON NUTRITION AND PHYSICAL ACTIVITY - JANPA KICK-OFF MEETING LUXEMBOURG, 29-30 SEPTEMBER 2015 WORK PACKAGE 4: LIFETIME COST OF CHILDHOOD OBESITY Lead: Prof. Kevin Balanda Institute of Public
METASTATIC BREAST CANCER
A POLICY ROADMAP ON ADDRESSING METASTATIC BREAST CANCER OCTOBER 2017 a multi-stakeholder collaboration Endorsed by This document was drafted by the Expert Working Group on metastatic breast cancer. Drafting
METASTATIC BREAST CANCER
A POLICY ROADMAP ON ADDRESSING METASTATIC BREAST CANCER OCTOBER 2017 a multi-stakeholder collaboration Endorsed by This document was drafted by the Expert Working Group on metastatic breast cancer. Drafting
Retina International General Assembly Auckland, New Zealand
Retina International General Assembly 2018 - Auckland, New Zealand Thursday, February 8th, 2018 Location: University of Auckland Business School Owen G Glenn Building, 12 Grafton Road, Auckland, 1010 Room:
Spreading Excellence and Widening Participation
Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs
the patients perspective and role of epags
Patients Registry in ERNs: the patients perspective and role of epags 5th International Summer School Rare Disease & Orphan Drug Registries VirginieBros-Facer, Research Infrastructure Project Manager 18
Thyroid cancer registration in Belgium: from data collection to population-based research. 1
Thyroid cancer registration in Belgium: from data collection to population-based research 1 Harlinde De Schutter, December 3rd 2016 Legal and administrative milestones of BCR 2010 2002 KB-AR MOC-CMO 2005
AESGP views. Johannes Koch, Head of European Policy and International Affairs German Medicines Manufacturers' Association BAH. Who is AESGP?
The international Generic Drug Regulators Programme (IGDRP): an initiative to further strengthen collaboration, promote regulatory convergence and improve worksharing at a worldwide level EDQM premises
1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.
Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social
Cancer in adolescents and Young Adults
17 th ESO-ESMO Masterclass in Clinical Oncology 24-29 March 2018, Cancer in adolescents and Young Adults Laurence Brugières Gustave Roussy Cancer Center Villejuif, France Cancer in TYA A rare disease in
Establishment of networks of human and animal virology laboratories and medical entomology
Establishment of networks of human and animal virology laboratories and medical entomology Maria Grazia Dente, Flavia Riccardo and Silvia Declich CNESPS/Istituto Superiore di Sanità -ISS (Italy) Workshop
8-13 March 2014 Ermatingen (Lake Constance), Switzerland
REPORT 13 th ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY Chairs: N. Pavlidis, GR - R. A. Stahel, CH Scientific Coordinators: W. Gatzemeier, IT - R. Popescu, CH Course coordination / Management: F. Marangoni,
14 December :00 CET
Webinar IMI2 Call 13 Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches 14 December 2017 15:00 CET Agenda How to use
European Cancer Patient Coalition Action Plan Empowering Europeans affected by cancer
European Cancer Patient Coalition Action Plan 2018 Empowering Europeans affected by cancer Publisher Published by the European Cancer Patient Coalition European Cancer Patient Coalition, 2017 Correspondence
Health Programme support to the European Action Plan HIV/AIDS
Health Programme 2008-2013 support to the European Action Plan HIV/AIDS 2009-2012 Executive Agency for Health and Consumers EAHC Cinthia Menel Lemos Cinthia.menel-lemos@ec.europa.eu What are the news?
EORTC : 54 ans de recherche académique. 12ème Biennale Monégasque de Cancérologie 5 février 2016
EORTC : 54 ans de recherche académique 12ème Biennale Monégasque de Cancérologie 5 février 2016 FRANCOISE MEUNIER, MD, PhD, FRCP Director Special Projects, EORTC Brussels, Belgium Table of contents General
Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.
Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Yolande Lievens, MD, PhD Chair Radiation Oncology Department, Ghent University Hospital Co-Chair HERO
in cooperation with the World Health Organization Hanoi, Vietnam
Workshop of the WBMT in cooperation with the World Health Organization Hanoi, Vietnam Dissemination of Information Nov 11, 2011 (15:30) David Ma Nov 2011 Objectives To discuss strategies on how best to:
GENERAL OBJECTIVE OF THE JATC. Support the implementation of the Tobacco Products Directive throughout the 28 EU MS
www.jaotc.eu GENERAL OBJECTIVE OF THE JATC Support the implementation of the Tobacco Products Directive throughout the 28 EU MS The TPD aims to preserve a high level of European public health and support
Council of the European Union Brussels, 28 October 2015 (OR. en)
Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft
EUROPEAN JOINT PROGRAMME ON RARE DISEASES DARIA JULKOWSKA INSERM, FRANCE
EUROPEAN JOINT PROGRAMME ON RARE DISEASES DARIA JULKOWSKA INSERM, FRANCE RARE DISEASES LANDSCAPE IN EUROPE STRATEGY FUNDING RARE DISEASES RESEARCH INFRA STRUCTURES HEALTH CARE + PATIENTS NEEDS 2 IRDiRC
How Italy and France take on rare sarcoma cancers
Page 4 of 12 Road safety road transport Trucks and CO2 1. Home 2. News 3. Health 4. How Italy and France take on rare sarcoma cancers How Italy and France take on rare sarcoma cancers By Hannah Black and
Pfizer Support to European and International Patient Organisations in 2008
Pfizer Support to European and International Patient Organisations in 2008 The EFPIA Code on Relationships between the Pharmaceutical Industry and Patient Organisations came into force across Europe on
OPEN FORUM ROME 19 & 20 June 2012
Joint Action OPEN FORUM ROME 19 & 20 June 2012 Spotlight on Health Promotion & Prevention and Cancer Data & Information (Work Packages 5 & 9) Hosted by the Italian Ministry of Health, Rome, Italy This
Empowerment, healing and transformation for women moving on from violence
Mental Health Advocate - Job Description (April 2017) Job Title: Responsible To: Mental Health Advocate Mental Health Services Manager Organisational Context Women and Girls Network (WGN) WGN is a pan-london
6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.
MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe
GENERAL OBJECTIVE OF THE JATC. Support the implementation of the Tobacco Products Directive throughout the 28 EU MS
www.jaotc.eu GENERAL OBJECTIVE OF THE JATC Support the implementation of the Tobacco Products Directive throughout the 28 EU MS The TPD aims to preserve a high level of European public health and support
OPTIMISING COLLABORATIONS TO FOSTER INNOVATION. R&D UNICANCER, the leading French academic clinical research organisation in oncology
OPTIMISING COLLABORATIONS TO FOSTER INNOVATION R&D UNICANCER, the leading French academic clinical research organisation in oncology ACADEMIC EXCELLENCE IN CANCER RESEARCH, FOR THE BENEFIT OF THE PATIENTS
US-EC cooperation in the area of obesity and nutritional sciences research
US-EC cooperation in the area of obesity and nutritional sciences research 21th meeting of the EC-US Task Force on Biotechnology Research 24 June 2011 Washington D.C., U.S. Isabelle de Froidmont-Görtz
ESSO Advanced Course on Primary Liver Tumours
ESSO Advanced Course on Primary Liver Tumours 24-25 April 2014 LIVERPOOL (UK) Endorsed by ESSO Advanced Course on Primary Liver Tumours Chair Hassan Malik, University Hospital Aintree NHS Trust, Liverpool,
Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children
Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children Dr Oscar Della Pasqua WP 4 11th June 2013 Strathclyde University, Glasgow, UK Project AIMS
MS Barometer A means of measuring MS management and quality of life of Persons with Multiple Sclerosis
A means of measuring MS management and quality of life of Persons with Multiple Sclerosis In 2008, the European Multiple Sclerosis Platform launched the MS Barometer as a new means to provide for the first
3RD ESO-ESMO LATIN-AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY April 2017 San Jose, Costa Rica LATIN-AMERICA PROGRAMME
3RD ESO-ESMO LATIN-AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY 26-30 April 2017 San Jose, Costa Rica Chairs: A. Cervantes, ES - N. Pavlidis, GR R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F.
Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-cf bronchiectasis (BE)
Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-cf bronchiectasis (BE) Dr. Juliane Bernholz, Novartis (Coordinator) Dr. Andrea Appenzeller,
Cleveland Clinic Laboratories. Anatomic Pathology
Cleveland Clinic Laboratories Anatomic Pathology OUR MISSION Cleveland Clinic Laboratories contributes to excellent patient care by providing high-quality, comprehensive laboratory testing and patient-focused
EXCELLENCE AND INNOVATION
EXCELLENCE AND INNOVATION FOR CANCER TREATMENT THE CENTRE LÉON BÉRARD Non-profit private health care facility of public interest (ESPIC), affiliated with the French National Cancer Center Federation UNICANCER
The Committee for Medicinal Products for Human Use
www.eurordis.org The Committee for Medicinal Products for Human Use Patrick Salmon HPRA Barcelona, 4th June, 2015 2 CHMP 3 CHMP Move 4 The New CHMP 5 Where it all happens! 6 CHMP... What is it? CHMP What
Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES
08-04-2017 12:45-13:00 Type: Educational session Title: Welcome and Introduction by the Chairs 1 2 1 2 Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES 12:45-13:00 Welcome 13:00-13:15
Transparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October
Transparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October 2. 2017. Transparency - A tool to drive change and innovasion? Breaking the
DELIVERABLE REPORT. Grant Agreement number:
Laser and Ultrasound Co-Analyzer for thyroid nodules DELIVERABLE REPORT Grant Agreement number: 688303 Project acronym: LUCA Project title: Laser and Ultrasound Co-Analyzer for thyroid nodules Funding